Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 404(1): 90-5, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-21094128

ABSTRACT

3ß-Hydroxy-5,6-secocholestan-6-al (cholesterol secoaldehyde or ChSeco), an oxysterol known to be formed in ozone- and singlet oxygen-mediated oxidations of cholesterol, has been detected in the atherosclerotic plaque and in the brain of patients suffering from Alzheimer's disease and Lewy body dementia. Previously, we have shown that, in H9c2 cardiomyoblasts, ChSeco induces oxidative stress followed by apoptosis involving both intrinsic and extrinsic signaling pathways. In the present study, we investigated the nature of reactive oxygen species (ROS) and its associated redox signaling in H9c2 cells upon treatment with ChSeco. Both catalase and deferoxamine, which lowered intracellular ROS, were found to alleviate the ChSeco-induced cytotoxicity. ChSeco-treated H9c2 cells showed a significant decrease in the intracellular catalase activity, suggesting the involvement of H(2)O(2) in the associated cytotoxicity. Additionally, in ChSeco-exposed cells, there was a marked increase in lipid peroxidation and pre-treatment with SB 203580 (p38 MAPK inhibitor) and MEK1/2 inhibitor (ERK1/2 and JNK inhibitor) rendered protection against the cytotoxicity. An early increase in the expression of p-SAPK/JNK or delayed p38 MAPK did not alter ATF-2 but decreased c-Jun expression in these cells. Overall, these findings are consistent with MAPK signaling resulting from increased cellular H(2)O(2) in ChSeco-induced cytotoxicity in cardiomyoblasts.


Subject(s)
Cholestanones/toxicity , Hydrogen Peroxide/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Myoblasts, Cardiac/drug effects , Secosteroids/toxicity , Apoptosis , Cell Line , Humans , Imidazoles/pharmacology , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Myoblasts, Cardiac/enzymology , Pyridines/pharmacology , Reactive Oxygen Species/metabolism , Stress, Physiological
2.
Biochem Biophys Res Commun ; 389(2): 382-7, 2009 Nov 13.
Article in English | MEDLINE | ID: mdl-19733550

ABSTRACT

Cholesterol secoaldehyde (3beta-hydroxy-5-oxo-5,6-secocholestan-6-al or ChSeco) is an oxysterol known to be formed in reactions of ozone with cholesterol and also when cholesterol-5alpha-hydroperoxide undergoes Hock cleavage. In view of its widespread occurrence and atherogenic potential, we examined the effects of ChSeco on mouse J774 macrophage viability and events associated with apoptosis. A dose-dependent decrease in cell viability, disruptions in mitochondrial transmembrane potential (64+/-5.5%; mean+/-SD, n=3), increased levels of cytosolic cytochrome c (8.8+/-0.84 ng/ml; mean+/-SD, n=3), activation of caspase-3 (ca. 3.6-fold) and caspase-9 (ca.1.8-fold), and increased DNA fragmentation (ca. 5-fold), all indicative of apoptosis, were observed in response to exposure to ChSeco. The apoptotic nature of cell death in macrophages was confirmed by dual staining with acridine orange and ethidium bromide. However, unlike the case with cardiomyoblasts and neuronal cells, the apoptotic process in these immune cells was not mediated by increased levels of reactive oxygen species as indicated by a minimal or no increase in 2',7'-dichlorofluorescein fluorescence. It is suggested that the apoptotic process is mediated via the mitochondrial pathway and that ChSeco formed in biological environments contributes to the initiation, progression, and culmination of atherosclerotic plaque formation, as these processes are critically dependent on macrophage apoptosis.


Subject(s)
Apoptosis , Cholestanones/metabolism , Cholesterol/metabolism , Macrophages/metabolism , Mitochondria/metabolism , Secosteroids/metabolism , Animals , Cell Line , Cholestanones/pharmacology , Cholesterol/pharmacology , Macrophages/drug effects , Mice , Reactive Oxygen Species/metabolism , Secosteroids/pharmacology
3.
Biochem Biophys Res Commun ; 386(1): 170-4, 2009 Aug 14.
Article in English | MEDLINE | ID: mdl-19505436

ABSTRACT

Cholesterol secoaldehyde (ChSeco or 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al) has been shown to induce Abeta aggregation and apoptosis in GT1-7 hypothalamic neurons. The present study was undertaken to evaluate the effects of ChSeco on rat primary cortical neuronal cells. ChSeco was cytotoxic at concentrations ranging from 5 to 20 microM, while cholesterol of comparable concentrations showed little or no toxicity. In ChSeco-exposed neuronal cells, there was an increased formation of intracellular peroxide or peroxide-like substance(s), the levels of which were comparable to those found in typical menadione exposures. There was a loss in the mitochondrial transmembrane potential, the extent of which was dependent on concentration of ChSeco employed. Pre-treatment with N-acetyl-L-cysteine (5 mM; 1 h) offered protection against the cytotoxicity and the generation of intracellular oxidants. Cytotoxicity of ChSeco was evidenced by the loss of axonal branches and also condensed apoptotic nuclei in these cells. Immunohistochemical analysis revealed a decreased intracellular Abeta42 staining proportional to the loss in the axonal out growth and dendritic branches. The observed decrease in Abeta42 has been suggested to be due to loss of integrity of dendrites and the plasma membrane, possibly resulting from increased production of reactive oxygen species.


Subject(s)
Cerebral Cortex/drug effects , Cholestanones/toxicity , Neurons/drug effects , Oxidative Stress , Secosteroids/toxicity , Acetylcysteine/pharmacology , Amyloid beta-Peptides/metabolism , Animals , Cells, Cultured , Cerebral Cortex/metabolism , Cholestanones/metabolism , Membrane Potential, Mitochondrial/drug effects , Peptide Fragments/metabolism , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Secosteroids/metabolism
4.
J Med Microbiol ; 51(4): 350-357, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11926742

ABSTRACT

DNA-based vaccines were employed to assess protective immunity against herpes simplex virus in experimental infections of hairless (strain SKH1) and BALB/c mice. Mice were vaccinated with plasmids containing the herpes simplex virus type-1 (HSV-1) glycoprotein B (gB) or D (gD) genes under the human cytomegalovirus immediate-early promoter control. Vaccines were injected intramuscularly (i.m.) or intraperitoneally (i.p.) as purified DNA alone or as formulations supplemented with different non-ionic block copolymers. Antibody responses were assessed by immunofluorescence and radio-immunoprecipitation assays. Mice inoculated with either gB or gD plasmid, alone or with non-ionic block copolymers CRL 1029 and CRL 1190, produced high levels of antibodies specific for gB or gD. Three weeks after the last vaccination, mice were challenged with a clinical HSV-1 isolate (ABGK-1) by inoculation of a shaved and subsequently scarified area between the third and fourth lumbar vertebrae. Mice immunised with either gD or gB plasmid alone or mixed with copolymers were protected against lethal HSV-1 challenge when immunisation was performed via the i.m. route. Immunisations given via the i.p. route induced humoral responses in some mice and protected the animals against lethal HSV-1 challenge only when the formulations contained copolymers. The BALB/c mouse model was shown to be as good a model as the hairless mouse model.


Subject(s)
Herpes Simplex Virus Vaccines , Herpes Simplex/prevention & control , Herpesvirus 1, Human/immunology , Vaccines, DNA , Viral Envelope Proteins/genetics , Animals , Antibodies, Viral/blood , Chlorocebus aethiops , Female , Fluorescent Antibody Technique, Indirect , Herpes Simplex Virus Vaccines/administration & dosage , Herpes Simplex Virus Vaccines/immunology , Herpesvirus 1, Human/genetics , Herpesvirus Vaccines/administration & dosage , Herpesvirus Vaccines/immunology , Humans , Injections, Intramuscular , Injections, Intraperitoneal , Male , Mice , Mice, Hairless , Mice, Inbred BALB C , Radioimmunoprecipitation Assay , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology , Vero Cells , Viral Envelope Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...